MK-7252

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-7252, covering 2020-01-09 to 2020-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of MK-7252 in Healthy Adult Participants (MK-7252-001) [Phase 1]